| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
2 MRC Clinical Sciences Centre, Imperial College London, London, United Kingdom
3 MRC Clinical Sciences Centre, Imperial College London, London, United Kingdom; Genetix Ltd., Queensway, Hampshire, United Kingdom
4 Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom
5 Biomedical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom
6 Genetics & Genomics Research Institute, Imperial College London, London, United Kingdom
* To whom correspondence should be addressed. E-mail: jlg40{at}mole.bio.cam.ac.uk.
In functional genomics DNA microarrays for gene expression profiling are increasingly being used to provide insights into biological function or pathology. To better understand the significance of the multiple transcriptional changes across a time period the temporal changes in phenotype must be described. Orotic acid induced fatty liver disease was investigated at the transcriptional and metabolic levels using microarrays and metabolic profiling in two strains of rats. High resolution 1H NMR spectroscopic analysis of liver tissue indicated that Kyoto rats compared to Wistar rats are predisposed to the insult. Metabolite analysis and gene expression profiling following orotic acid treatment identified perturbed metabolic pathways, including those involved in fatty acid, triglyceride, and phospholipid synthesis, 
-oxidation, altered nucleotide, methyl donor and carbohydrate metabolism, and stress responses. Multivariate analysis and statistical bootstrapping were used to investigate co-responses with transcripts involved in metabolism and stress responses. This reverse functional genomic strategy highlighted the relationship between changes in the transcription of stearoyl-CoA desaturase 1 and those of other lipid related transcripts with changes in NMR-derived lipid profiles. The results suggest that the integration of 1H NMR and gene expression datasets represents a robust method for identifying a focused line of research in a complex system.
This article has been cited by other articles:
|
|
 |
|
  J. L. Griffin and A. Vidal-Puig Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics, June 10, 2008; 34(1): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Liang and B. Ventura Physiological genomics in PG and beyond: October to December 2005 Physiol Genomics, December 14, 2005; 24(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Mutch, W. Wahli, and G. Williamson Nutrigenomics and nutrigenetics: the emerging faces of nutrition FASEB J, October 1, 2005; 19(12): 1602 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Lelliott, M. Lopez, R. K. Curtis, N. Parker, M. Laudes, G. Yeo, M. Jimenez-Linan, J. Grosse, A. K. Saha, D. Wiggins, et al. Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis FASEB J, July 1, 2005; 19(9): 1108 - 1119. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
